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The emergence and spread of drug-resistant bacteria pose a
great global health threat, as they are outpacing the develop-
ment of novel antibiotics. Prominent examples are multidrug-
resistant (MDR) and extensively drug-resistant (XDR) strains of
Mycobacterium tuberculosis (Mtb) that cause highly lethal tuber-
culosis (TB). The aminoglycoside (AG) kanamycin (Kan) is often
chosen as a drug of last resort to treat such infections. It was
recently discovered that upregulation of the enhanced intracel-
lular survival (eis) gene was the sole cause of resistance to Kan
in one-third of a large and diverse set of Mtb clinical isolates.[1]
Most recently, specific mutations in the eis gene in XDR-Mtb
strains were found to be strongly associated with resistance to
all AGs and to the amine-rich peptide capreomycin, another
drug used in MDR-TB and XDR-TB therapy.[2] The eis gene enco-
des the acetyltransferase Eis, and the increased acetylation of
Kan upon upregulation of eis causes the resistance,[1a] as the
acetylated Kan cannot bind to its target, the ribosome. We pre-
viously demonstrated that, unlike other known AG acetyltrans-
ferases (AACs), all of which regiospecifically acetylate a single
position on any given AG, Eis from Mtb and its homologues
from other bacteria[3] can efficiently transfer the acetyl group
from acetyl coenzyme A (AcCoA) to multiple amine functionali-
ties on a variety of lysine-containing peptides, including cap-
reomycin,[4] and AG scaffolds, including Kan and amikacin
(Amk).[5] Eis is also unique structurally ; it is a hexamer, with
each monomer composed of three fused domains: the N-ter-
minal GNAT domain, which bears most of the residues directly
involved in AcCoA binding and catalysis of acetyl transfer, the
central cyclically permuted GNAT domain that, together with
the N-terminal GNAT domain, forms an intricate AG binding
pocket, and the C-terminal domain, with a sterol binding pro-
tein fold that performs the scaffolding role and positions the
C-terminal carboxy group in the active site to serve as a general
base in acetyl transfer. Despite this progress, the mechanistic
picture of the intriguing multi-acetylation capability of Eis has
remained unclear. In this study, we carried out a detailed inves-
tigation of the specificity and order of multi-acetylation of five
clinically relevant AGs by Eis from Mtb by using a combination
of thin-layer chromatography (TLC) and nuclear magnetic reso-
nance (NMR) spectroscopy. We discovered acetylation at posi-
tions that are not modified by any other known AAC. In addi-
tion, we determined the crystal structure of a ternary complex
of Eis with coenzyme A (CoA) and one of the AGs, tobramycin
(Tob), to characterize the substrate binding features, which re-
vealed two possible binding modes of this AG in the Eis active
site, consistent with the two positions acetylated on Tob.
Results and Discussion
Analysis of positions and the order of acetylation of AGs by
Eis from Mtb
Eis is unique among all AACs in exhibiting regioversatility ; it
efficiently acetylates several AGs at multiple amine positions.[5]
Other known AACs are strictly regiospecific and are divided
into classes based on the sites that they acetylate. AAC(6’),
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AAC(2’), AAC(3), and AAC(1) have been reported, and represen-
tatives of AAC(6’), AAC(2’), AAC(3) were used in this study to
obtain acetylated AGs to be used as standards. TLC was used
to study AG acetylation, as the retention factor (Rf) of AGs
changes upon acetylation. We compared the Rf values for Eis-
modified Amk, Kan, sisomicin (Sis), netilmicin (Net), and Tob to
the respective 6’-, 2’-, and 3-mono-acetylated counterparts,
and, when possible, to their 6’,2’-, 6’,3-, and 3,2’-diacetylated
counterparts (Table 1). The diacetylated standards were ob-
tained by sequential acetylation with the selective AACs as
previously described.[5,6]
Previous studies indicated that Kan and Amk were readily di-
acetylated by Eis, and that the 4-amino-2-hydroxybutyryl
(AHB)-containing Amk could be triacetylated to some extent,
as determined by liquid chromatography-mass spectrometry
(LCMS), but the positions and the order of acetylation were
not established.[5] Following the reaction progress by TLC and
LCMS revealed that Kan underwent two acetylations relatively
rapidly, and the modifications did not follow a strict order
(Figure 1 and Table 1, Figure S1 and Table S1). The Rf value of
the diacetylated Kan product of Eis did not match that of any
acetylated standards, thus indicating at least one position to
be novel. The diacetylated product from a scaled-up reaction
was purified by silica gel flash chromatography for NMR analy-
sis (Tables S2-3, Figure S2-11). A comparison of the 1D and 2D
1H and 13C NMR spectra of Kan to the diacetylated Kan product
clearly indicated that the reactions occurred at the 6’- and 3’’-
amines. This is the first report of acetylation at the 3’’-position
of any AG by an AAC.
TLC analysis of the acetylation of Amk by Eis indicated that
as many as three acetylated products could be formed and
that, similarly to Kan, their formation did not follow a strict
order (Figure 1 and Table 1). Among the regiospecific AAC en-
zymes mentioned earlier, Amk is a good substrate only for
AAC(6’), which limits available standards and thereby limits the
utility of TLC in determining the Eis regiospecificity for this AG.
Of the three products formed by Eis that were resolved by
TLC, the one with the lowest Rf value closely matched that of
6’-acetyl-Amk. The reaction was scaled up and purified by silica
gel flash chromatography for 1D and 2D 1H NMR analysis
(Table S4, Figures 2 and S12–18). NMR analysis revealed that
the dominant ultimate product with an Rf value of 0.46 was an
Amk that was diacetylated similarly to Kan, but, to our surprise,
in this case the reactions had occurred at the 3’’-position and
the g-amine of the AHB moiety. This is the first report of an
AAC capable of modifying the AHB moiety of Amk. It is impor-
tant to note that for Amk, Net, Sis, and Tob, NMR experiments
were performed in 10% D2O, which provided two means of
determining the exact positions acetylated: 1) visualization of
amide proton coupling in 2D spectra, and 2) chemical shift pat-
terns.
In contrast to Amk and Kan, for which multiple acetylations
followed a random order, TLC analysis of the time course of
acetylation of Sis and Net by Eis showed that the reactions
proceeded in an ordered sequential manner, with the second
acetylation occurring significantly more slowly than that ob-
served for Kan or Amk (Figure 3 and Table 1). For both Sis and
Net, TLC indicated that Eis specifically and rapidly acetylated
a single amine, and a comparison with the standards strongly
suggested that the amine at the 6’-position was acetylated.
For Net, the first acetylation was followed by a single second
acetylation, and for Sis, by two slow acetylations. In order to
determine the order of acetylation, we modified our method
to monitor reaction progress by NMR without the need for
time-consuming chromatographic separation and purification
of the products. AcCoA was added in a stepwise fashion over
Table 1. Rf values
[a] of mono- and diacetylated AGs by the AAC(2’)-Ic, AAC(3)-IV, AAC(6’), and Eis proteins.
Enzymes utilized
None (2’)[e] (3)[f] (6’)[g] (3)/(2’) (6’)/(2’) (6’)/(3) Eis
AG 1 min 5 min 10 min 30 min 2 h O/N
Amk parent[b] 0.06 0.06 0.06 0.06 0.06
mono[c]  [h]  [i] 0.10 0.10/0.36 0.10/0.36 0.10/0.36 0.10/0.36
di[d]  [h]  [h]  [i] 0.46 0.46
Kan parent 0.28 0.28
mono  [h] 0.33 0.43 0.33 0.33/0.43 0.33/0.43 0.33/0.43 0.33
di  [h]  [h] 0.49 0.56 0.56
Net parent 0.06  [j]  [j]  [j]  [j]
mono  [j]  [j] 0.26 0.26
di –[k] 0.37 0.41 0.37
Sis parent 0.05
mono 0.08 0.16 0.24 0.24 0.24 0.24 0.24 0.24
di 0.23 0.26 0.30 0.24–0.30
Tob parent 0.24 0.24 0.24
mono 0.27 0.36 0.48 0.48 0.29/0.48 0.48 0.48
di –[k] –[k] 0.71 0.62 0.62 0.62 0.62
[a] The eluent systems used for TLC were MeOH/NH4OH (5:2 for Amk, Kan, and Tob; 25:1 for Net; and 15:2 for Sis). [b] Parent indicates no acetylation.
[c] Mono indicates monoacetylation. [d] Di indicates diacetylation. [e] (2’) indicates AAC(2’)-Ic. [f] (3) indicates AAC(3)-IV. [g] (6’) indicates AAC(6’) of the
AAC(6’)/APH(2’’). [h] Because the 2’-NH2 does not exist in Amk or Kan, these controls were not performed. [i] Amk is not a substrate for AAC(3)-IV. [j] These
reactions were not performed. [k] Indicates that the diacetylated product could not be visualized as it had an Rf value overlapping with that of the glycerol
in the reaction mixture, as the sequential use of enzymes did not work in these cases. [l] Based on NMR analysis, this most likely corresponds to the 3’’-
acetyl-Tob.
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the course of the reaction to control the reaction progress and
facilitate identification of monoacetylated species. NMR analy-
sis of a reaction mixture containing a 1:1 molar ratio of AcCoA
and Net showed rapid and complete conversion to the 6’-ace-
tylated product, as suggested by TLC (Table S5, Figure S19–24).
Addition of a second equivalent of AcCoA yielded a single
diacetylated product. This second sequential acetylation oc-
curred at the 2’-amine to give the 6’,2’-diacetyl-Net product
(Table S6, Figure S19–21 and S25–27).
For Sis, NMR analysis was carried out in a similar fashion. At
a 1:1 molar ratio of AcCoA and Sis, complete conversion to 6’-
acetyl-Sis was observed (Table S7, Figure S28–36). The Rf values
of the two additional Eis acetylated Sis products were similar
to two diacetylated Sis standards, 6’,2’- and 6’,3-diacetyl-Sis.
These products formed much more slowly than in the previous
cases and required addition of four equivalents of AcCoA and
prolonged overnight incubation to drive the reaction to com-
pletion from 6’-acetyl-Sis. A mixture of the two products was
purified by flash chromatography for further NMR experiments
(Table S8, Figure S28–33 and S37–42). The relatively small dif-
ference in Rf values precluded complete separation of these
two products ; therefore, NMR analysis was carried out on
a mixture of these two compounds. The analysis indicated that
Sis was converted into two distinct diacetylated products, and
that a triacetylated product was formed in amounts insufficient
for its characterization. One of the products was unambiguous-
ly determined to be 6’,2’-diacetyl-Sis (Figure 3). The second
diacetylated product contained an acetyl group in ring II at
either the 1- or 3-position; the exact position could not be
assigned with certainty, as the amine at these two positions
overlap in NMR spectra and cannot be differentiated by 2D
NMR due to the pseudo-symmetrical substitution of ring II.
We further performed similar experiments on Tob because it
contains a different pattern of functionalities in ring I, and is
otherwise identical to Kan. Previous LCMS analysis showed
that Tob can be acetylated by Eis at as many as four posi-
tions.[5] TLC characterization and mass spectrometry experi-
ments indicated that two dominant acetylations occurred and
Figure 1. AGs acetylated in random order by Eis. Top: Diacetylation of AMK by Eis observed by TLC. Lanes 1 and 7: Amk. Lanes 2–6 and 8: time course display-
ing the mono- and diacetyl-Amk products of the Eis reaction. Lane 9: control for 6’-acetylation of Amk performed with AAC(6’). Middle: Diacetylation of Kan
by Eis observed by TLC. Lanes 1–7: time course displaying the mono- and diacetyl-Kan products of the Eis reaction. Lanes 8–10: controls for the mono- and
diacetylation of Kan performed with AAC(6’) and AAC(3)-IV individually or sequentially. Bottom: Diacetylation of Tob by Eis observed by TLC. Lanes 1–7: time
course displaying the mono- and diacetyl-Tob products of the Eis reaction. Lanes 8–11: controls for the mono- and diacetylation of Kan performed with
AAC(6’), AAC(3)-IV, and AAC(2’)-Ic individually or sequentially.
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that they were not strictly ordered, as with Kan and Amk (Fig-
ures 1 and S1, Tables 1 and S1). Comparison with acetylated
Tob standards indicated that one of the first acetylations likely
occurred at the 6’-amine, whereas the other mono-acetylated
product did not match any of the standards. NMR analysis of
the reaction containing a 1:1 molar ratio of Tob and AcCoA
indicated that the two monoacetylated products formed in an
approximately 6:4 ratio. Addition of another equivalent of
AcCoA resulted in the complete conversion of Tob to a single
6’,3’’-diacetylated product (Table S9, Figure S43–48), demon-
strating the same regiospecificity of Eis towards Tob and Kan.
Effect of acetylation of Amk, Kan, Net, Sis, and Tob by Eis on
the antibiotic activity of these AGs
Both Kan and Amk are inactivated upon Eis acetylation, as pre-
viously demonstrated by bio-TLC assays.[1a] We tested the
effect of multiple acetylations of the AGs by Eis on their antibi-
otic activity against Escherichia coli and Mycobacterium smeg-
matis in disc diffusion assays. These experiments demonstrate
that all five AGs: Amk, Kan, Net, Sis, and Tob, lose their antibi-
otic activity against E. coli and M. smegmatis upon multiacetyla-
tion by Eis (Figure 4).
Crystal structure of Eis in complex with CoA and Tob
Capturing a stably bound AG in the active site of Eis in crystals
has been a significant challenge. This is likely, at least in part,
due to binding of the AG in multiple orientations in the Eis
active site to position different amines for acetylation. Previous
co-crystallization experiments of Eis, Eis-CoA, and Eis-AcCoA
with several AGs did not reveal a clear electron density for an
AG.[5] Soaking these crystals with a variety of AGs also did not
yield a structure with a bound AG. We observed that, in addi-
tion to one CoA molecule bound at its cognate site (essential
for Eis crystal formation), another CoA formed a disulfide bond
to the thiol of Cys204 upon oxidation over the long crystalliza-
tion times needed for crystal growth, as evidenced by the
presence of partial electron density for this CoA adduct in
some electron density maps. Because Cys204 is located close
to the entry of the AG binding pocket, this spurious CoA
adduct formation might obstruct or partially occlude binding
of an AG, thus destabilizing its Eis-bound state. To remove this
artifact of long incubation, we generated the EisC204A mutant.
This mutant displayed similar acetylation efficiency to that of
wild-type Eis for several AGs (Figure S49). A crystal structure
with an AG bound to Eis was obtained from crystals of an
EisC204A-CoA-Tob complex and refined at 3.5  resolution
(Table 2). Two of the six AG binding pockets of the Eis hexamer
contained strong and continuous difference electron density
corresponding to the bound Tob (Figure 5). This electron den-
sity did not have a sharply delineated boundary, possibly due
to resolution limitations or due to Tob binding to the Eis active
site pocket in two or more binding modes, each partially occu-
pied in the crystal. A Tob molecule could be refined in either
one of two possible binding modes, approximately related to
each other by a 1808 rotation, a shift and a minor conforma-
tional change (Figure 5C, D). These two binding modes are
consistent with the two dominant acetylations of Tob, one at
the 6’-position (Figure 5C) and the other at the 3’’-position
(Figure 5D). Moreover, both the conformation and position of
Tob in the active site consistent with 6’-acetylation closely re-
semble those in the crystal structure of AAC(6’)-Ig from Acine-
tobacter haemolyticus in complex with Tob (PDB code: 4EVY).
As previously predicted, the Tob-interacting residues are locat-
ed in all three regions of Eis.[5] In either conformation, Tob is
held in the binding pocket by several direct electrostatic and
hydrogen bonding interactions between the amine and hy-
droxy groups of the Tob with protein carboxylates (Asp26,
Figure 2. A representative zTOCSY spectrum recorded at 600 MHz in H2O/
D2O (9:1) showing the 3’’,AHB-diacetyl-Amk. The full spectrum is shown in
panel A, and the expansion showing the amide protons coupled to the
protons at the 1-, 3’’-, and AHB-positions in panel B. The box in panel A
indicates the portion of the spectrum expanded and shown in panel B. In
panel B, coupling of the amide protons at the 1-, 3’’-, and A3 of the AHB
positions are indicated by boxes with different shades of gray.
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Glu203, Glu401, and the C-terminal carboxy group). In addition,
the Tob molecule is cradled by nonpolar contacts between its
rings and the nonpolar side chains (Ile28, Trp36, Phe24, and
Phe84). Specifically, the modified sugar ring is oriented by con-
tacts with Phe24 and Phe84, and the ring distal from the modi-
fication site makes hydrophobic contacts with Ile28 and Trp36.
Stacking of sugar rings against aromatic residues or RNA bases
appears to be a general mode of interaction seen in other crys-
tal structures in which Tob is a ligand.[7] The unique pocket
structure of Eis among AG-modifying enzymes results in the
unique nature of its interactions with Tob in the following re-
spects. A Tob molecule bound to Eis-CoA is highly protected
from solvent, more so than in any other structurally character-
ized protein-Tob complex (Table S10). Solvent-accessible sur-
face area analysis indicated that this extra desolvation is due
to the nonpolar Tob-Eis interactions not seen in other protein-
Tob structures. In fact, nonpolar
surface area buried in the Tob-
Eis interface dominates buried
polar surface area, in contrast to
other protein-Tob complexes
(Table S11). The larger contribu-
tion of nonpolar residues lining
the AG binding pocket of Eis,
compared with other AG-modi-
fying enzymes, might explain
the versatility of binding an AG
in different conformations, as
strict geometric constraints im-
posed by hydrogen bonds and
electrostatic interactions, which
generally dictate a particular ori-
entation of a bound substrate,
appear to play a relatively
minor role in the case of Eis.
Conclusions
Herein we investigated the re-
gioversatility of the AAC Eis and
demonstrated that this enzyme
is unique in its capability to
acetylate the 3’’-position of
Amk, Kan, and Tob, as well as
the g-amine of the AHB group
of Amk. Neither position is
known to be modified by any
other characterized AAC. Inter-
estingly, a previous report impli-
cated point mutant D80G of
AAC(6’)/APH(2’’) from Staphylo-
coccus aureus in arbekacin ace-
tylation at the g-amine of the
AHB group,[8] which was ob-
served in bacterial extracts con-
taining this mutant enzyme.[9]
Similarly to inactivating acetyla-
tions by Eis and other AACs at other positions, these two
newly discovered modifications are predicted to destabilize
AG-ribosome binding, as these amines form hydrogen bonds
with RNA bases in the decoding A-site of the ribosome.[10] The
acetyl groups at these positions might also disrupt other inter-
actions, as the acetylated AG would not be accommodated
sterically in the same bound conformation. Indeed, acetylation
of all five AGs examined in this study by Eis abolished their an-
tibiotic activity against both E. coli and M. smegmatis, confirm-
ing a similar observation made previously with Kan and
Amk.[1a] In addition to these unusual modifications, Eis can
acetylate AGs at one or more of all possible positions (1, 2’, 3,
and 6’) that were previously reported to be modified by other
AACs.[11] The multi-acetylation of AGs by Eis displays specificity,
as not all the amines are modified on any AG studied to date,
and similar AGs share some common modification positions.
Figure 3. AGs acetylated in strict order by Eis. Top: Diacetylation of Net by Eis observed by TLC. Lanes 1, 3, 4, and
7: time course displaying the mono- and diacetyl-Net products of the Eis reaction. Lanes 2, 5, and 6: controls for
the mono- and diacetylation of Net performed with AAC(6’), AAC(3)-IV, and AAC(2’)-Ic individually or sequentially.
Bottom: Diacetylation of Sis by Eis observed by TLC. Lanes 1–8 and 16: time course displaying the mono- and di-
acetyl-Sis products of the Eis reaction. Lanes 9 and 11–15: controls for the mono- and diacetylation of Net per-
formed with AAC(6’), AAC(3)-IV, and AAC(2’)-Ic individually or sequentially.
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Nevertheless, the regioversatility of Eis is truly remarkable, as
the acetylation specificity pattern depends on a particular AG
scaffold, as well as on the presence of modifications on the
same scaffold. For example, the AHB group of Amk, which nor-
mally renders its unmodified analogue, Kan, inert towards
modifications by some AG-modifying enzymes, switches Eis re-
giospecificity from the 3’’- and 6’-amines of Kan to the 3’’- and
AHB-amines of Amk. The large AHB adduct apparently disfa-
vors binding of Amk for its modification at the 6’-amine and
stabilizes an alternative bound conformation for acetylation of
the AHB-amine. Analogously, acetylation by Eis itself can alter
the binding mode of an AG to Eis, which explains the strictly
ordered acetylation of Sis and Net. It is possible that a relatively
high planarity of the unsaturated sugar rings of these two AGs
strongly stabilizes Sis and Net in one preferred Eis-bound con-
formation, due to the p–p stacking of these rings with protein
residues, similar to the the p–p stacking of the unsaturated
ring of 6’-hydroxy-Sis with the G1491 of decoding site RNA ob-
served recently by X-ray crystallography.[12] Acetylating these
AGs at one position creates a new, less charged surface on
these molecules, apparently making favorable new binding
modes for further acetylations. For Amk, Kan, and Tob, there
are at least two main orientations in which these AGs can bind
Eis initially, each leading to acetylation, as evidenced by
a random order of their acetylation.
The crystal structure of the ternary EisC204A-CoA-Tob com-
plex reveals the two possible binding modes of Tob that
would lead to its observed 3’’,6’-diacetylation. The structure
clearly shows a large contribution of nonpolar contacts of the
AG to the binding interface, both in the absolute sense and
relative to the nature of Tob contacts with other AG-modifying
enzymes. As a dominant contribution to the nonpolar contacts
is made by the interactions of Eis with the sugar scaffold of
Tob, resulting in nearly complete dehydration of Tob, a particu-
Figure 4. Disc diffusion assays demonstrating antibiotic activity of Kan, Amk,
Net, Sis, and Tob against E. coli BL21 (DE3) and M. smegmatis MC2-155 (discs
labeled “AG”) and abrogation of this activity upon acetylation of these AGs
by Eis (discs labeled “Ac-AG”).
Table 2. X-ray diffraction data collection and refinement statistics for the
EisC204A-CoA-Tob ternary complex structure.
Data collection
space group P21
number of monomers per asymmetric unit 6
Unit cell dimensions
a, b, c [] 82.2, 154.9, 115.3
a, b, g [8] 90, 104.7, 90
resolution [] 50.0–3.5 (3.56–3.50)[a]
I/s 14.9 (2.3)
completeness [%] 100.0 (99.7)
redundancy 3.8 (3.8)
Rmerge 0.10 (0.64)
number of unique reflections 33556
Structure refinement statistics
resolution [] 40.0–3.5
R [%] 24.6
Rfree [%] 27.6
bond length deviation (rmsd) from ideal [] 0.005
bond angle deviation (rmsd) from ideal [8] 1.100
Ramachadran plot statistics[b]
residues in most allowed regions [%] 92.1
residues in additional allowed regions [%] 7.9
residues in generously allowed regions [%] 0.0
residues in disallowed regions [%] 0.0 (0 residues)
[a] Numbers in parentheses indicate the values in the highest-resolution
shell. [b] Indicates Procheck statistics.[22]
Figure 5. Crystal structure of the EisC204A-CoA-Tob complex. A) View of the
Tob-containing active site in the EisC204A hexamer. B) The Tob-bound
EisC204A monomer. C) Tob bound in the conformation consistent with 6’-
acetylation. D) Tob bound in the conformation consistent with 3’’-acetyla-
tion. The black mesh is the omit FoFc electron density map generated with-
out Tob in the model and contoured at 3s. CoA, Tob, and Tob-interacting
residues of EisC204A are shown as yellow, red, and brown sticks, respective-
ly. The positions of acetylation and the N-1 position are labeled in red and
blue, respectively.
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lar binding mode of an AG, and hence its pattern of modifica-
tion, is generally guided by its core scaffold. The large N-1-AHB
group of Amk likely binds in the same binding channel with its
amine positioned for acetylation. This group could sterically
and electrostatically clash with Gly401 of Eis if Amk is posi-
tioned for its acetylation at the 6’-position, but not if Amk is
positioned for its acetylation at the 3’’-position, based on the
respective Tob binding modes (Figure 5C, D). In addition,
acetyl groups newly incorporated by Eis itself can alter binding
modes of an AG, at least in part by nonpolar stabilizing con-
tacts in the Eis substrate binding pocket, thereby positioning
another amine for acetylation.
The versatile acetylation of AGs and peptides by Eis[4] ap-
pears to be regulated in vivo, likely to avoid deleterious effects
of such acetylation of metabolites and proteins. This regulation
was reported to occur at the transcriptional level ;[13] no regula-
tory interacting partners of Eis are known. In fact, resistance to
Kan arises due to upregulating mutations in the eis promo-
ter.[1a] The highly versatile AG multi-acetylation function of Eis
is alarming in terms of the evolution of antibiotic resistance.
Together with the lack of effective treatments for TB, the in-
creasing number and severity of outbreaks of MDR- and XDR-
TB underscores an urgent need for discovery of novel drugs.
The development of novel synthetically modified AGs that
avoid resistance enzymes, reduce toxicity, and improve efficacy
has been the goal of numerous research efforts. However, the
combined versatility and promiscuity of Eis poses a hindrance
to the development of new AGs for TB treatment, particularly
because of the modification potential of Eis towards the AHB
moiety, which has been shown to improve resistance proper-
ties of many AGs when incorporated at the N-1 position.
Therefore, an alternative course of action might be necessary
to overcome TB resistance to AGs. One such approach is the
development of Eis inhibitors to be used in combination with
AGs against AG-resistant TB.[14] This approach mirrors a time-
tested b-lactam/b-lactamase inhibitor combination therapy
and the meropenem/clavulanate combination recently discov-
ered to be effective against XDR-TB.[15] The functional and
structural studies of Eis presented here bring us one step
closer to tackling the TB drug resistance problem.
Experimental Section
Materials and instrumentation : Eis,[5] AAC(2’)-Ic,[5] AAC(3)-IV,[6] and
AAC(6’)/APH(2’’)[6] were purified as before. NMR spectra were re-
corded on Bruker Avance III 600 MHz and Varian 400 and 500 MHz
spectrometers. LCMS was performed on a Shimadzu LCMS-2019EV.
TLC : TLC plates were stained with cerium molybdate.[5] The eluents
were MeOH/NH4OH (5:2 for Amk, Kan, Tob; 25:1 for Net; and 15:2
for Sis; Table 1).
TLC of monoacetylated AG standards : Reactions (15 mL) were per-
formed in MES (50 mm, pH 6.6) for AAC(3)-IV and AAC(6’) or in
Na2HPO4 (100 mm, pH 7.0) for AAC(2’)-Ic with AcCoA (0.96 mm), AG
(0.8 mm), and AAC (10 mm). After overnight incubation at room
temperature, an aliquot (5 mL) was loaded onto a TLC plate and
eluted.
TLC of diacetylated AG standards : Diacetylation reactions were
carried out with AAC(6’) followed by AAC(2’)-Ic, AAC(3)-IV followed
by AAC(2’)-Ic, or AAC(6’) followed by AAC(3)-IV. Reactions (10 mL)
were performed in MES (50 mm, pH 6.6) with AcCoA (1.92 mm), AG
(0.8 mm), and the first AAC (10 mm). After overnight incubation at
room temperature, the second AAC (10 mm) was added, and the re-
action proceeded for >16 h. An aliquot of each reaction (5 mL) was
loaded onto a TLC plate and eluted.
TLC of AGs multi-acetylated by Eis : Reactions (30 mL) were per-
formed in Tris-HCl (50 mm, pH 8.0) with AcCoA (4 mm), AGs
(0.8 mm), and Eis (5 mm). Aliquots (4 mL) were loaded onto a TLC
plate after 0, 1, 5, 10, 30, 120 min, and more than 16 h at room
temperature and eluted.
LCMS of multi-acetylated AG products : Masses were obtained in
positive-ion mode using H2O and 0.1% formic acid after dilution of
the NMR samples described below (1 mL of 15 mm stock) with H2O
(1 mL) and injection of 20 mL of each product (Table S1, Figure S1).
NMR analysis of 3’’,AHB-diacetyl-Amk : A reaction mixture (4 mL)
containing Amk (5 mm), AcCoA (20 mm), and Eis (0.5 mgmL1) in
Na2HPO4 (50 mm, pH 8.0) was incubated with shaking (room tem-
perature, 24 h) prior to adding extra AcCoA (5 mm), adjusting the
pH to 8.0 with 1.0m KOH, adding Eis (0.1 mgmL1), and incubating
for 48 h. After >90% conversion of Amk into diacetyl-Amk, as
judged by TLC, Eis was removed by MeOH precipitation. The su-
pernatant was evaporated, and the residue was purified by SiO2
flash chromatography using 0.0–2.0% Et3N in MeOH. Fractions
with product were pooled and concentrated under reduced pres-
sure. The residue was dissolved in D2O (minimal volume), adjusted
to pH 3 with sulfuric acid (0.5%), and lyophilized. 3’’,AHB-diacetyl-
Amk (white powder) was dissolved in D2O (400 mL), centrifuged,
and the supernatant collected for NMR analyses. The acetylated
positions and purity were confirmed by 1H, zTOCSY, and gCOSY
NMR and LCMS. Proton connectivity was assigned using zTOCSY
and gCOSY spectra. The NMR spectra of diacetylated-Amk (Fig-
ure S15–18) were compared to those of a non-acetylated Amk
standard (Figure S12–14), prepared similarly to 3’’,AHB-diacetyl-
Amk (Table S4). Additionally, the compound was prepared in H2O/
D2O (9:1), and
1H and zTOCSY spectra were acquired.
NMR analysis of 3’’,6’-diacetyl-Kan : Kan was diacetylated, and the
product (white powder) was purified analogously to 3’’,AHB-diace-
tyl-Amk. The acetylated positions and purity were confirmed by 1H,
13C, gCOSY, gHMBC, and gHSQC NMR and LCMS. Proton connectivi-
ty was assigned using 1H, zTOCSY, and gCOSY spectra. The signals
of all carbons were assigned by using 13C, gHSQC, and gHMBC
spectra. The NMR spectra of the diacetylated-Kan (Figure S7–11)
were compared to those of a non-acetylated Kan standard (Fig-
ure S2–6), prepared similarly to 3’’,6’-diacetyl-Kan (Tables S2–3).
NMR analysis of 2’,6’-diacetyl-Net : The reaction was monitored by
NMR without purification. To determine which modification oc-
curred first, a reaction (400 mL) containing Net (15 mm), AcCoA
(15 mm), and Eis (0.5 mgmL1) in Na2HPO4 (25 mm, pH 8.0) contain-
ing 10% D2O proceeded to >90% completion.
1H, gCOSY, and
zTOCSY NMR experiments were performed with PURGE solvent
suppression.[16] After the first acetylation was complete and all
spectra were acquired, AcCoA and Eis in 10% D2O were added to
yield a solution (600 mL) containing Net (10 mm), AcCoA (20 mm),
and Eis (0.1 mgmL1) in Na2HPO4 (25 mm, pH 8.0) containing 10%
D2O. Additional spectra were acquired after 48 h to determine the
second site of acetylation. The acetylated positions, purity, and
proton connectivity were analyzed as for Amk. The NMR spectra
were compared to those of a Net standard [15 mm in Na2HPO4
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(25 mm, pH 8.0) containing 10% D2O] prepared identically to the
reaction mixture without AcCoA and Eis (Tables S5–6). Representa-
tive spectra for 6’-acetyl-Net, 2’,6’-diacetyl-Net, and Net are provid-
ed in Figure S22–24, S25–27, and S19–21, respectively.
NMR analysis of 2’,6’- and 1/3,6’-diacetyl-Sis products : To deter-
mine the first position acetylated on Sis, the reaction was carried
out as described for Net by using ~0.05 mgmL1 of Eis. After the
first acetylation was complete and all spectra were acquired, ali-
quots of AcCoA (total of 4 equiv) were added, and spectra were ac-
quired after incubating for 48 h to determine the subsequent sites
of acetylation. Due to the complexity of the spectra, the final mix-
ture of diacetylated products was purified for further analysis. After
>90% conversion of Sis into two distinct diacetyl-Sis products, the
products (white powder) were purified analogously to 3’’,AHB-di-
acetyl-Amk. For NMR analyses, the mixture of products was dis-
solved in H2O:D2O (9:1, 400 mL), yielding a solution at pH 8 which
was centrifuged and the supernatant collected. However, the ac-
quired spectra were insufficient to fully characterize the com-
pounds. The pH was adjusted to 3 with sulfuric acid (0.5%) for fur-
ther analysis of the two diacetylated products. The acetylated posi-
tions, purity, and proton connectivity were analyzed as for Amk.
Representative spectra for 6’-acetyl-Sis and the mixture of 2’,6’-di-
acetyl-Sis and 1/3,6’-diacetyl-Sis are provided in Figure S34–36 and
S37–42, respectively. The NMR spectra were compared to those of
Sis standards at pH 3 and pH 8 prepared identically to the reaction
mixture without Eis and AcCoA (Tables S7–8). Representative spec-
tra of these standards are provided in Figure S31–33. Spectra of
the standard at pH 8 in H2O:D2O (9:1) are provided in Figures S28–
S30.
NMR analysis of 3’’,6’-diacetyl-Tob : To determine the first position
acetylated on Tob, the reaction (150 mL) was carried out as de-
scribed for Net by using ~0.02 mgmL1 of Eis. After one equivalent
of AcCoA was consumed, yielding a mixture of products (3’’- and
6’-acetyl-Tob), and all spectra were acquired, another equivalent of
AcCoA was added to form a single diacetylated product, 3’’,6’-di-
acetyl-Tob, and spectra were acquired after incubating for 12 h.
The NMR spectra were compared to those of a Tob standard
[15 mm in Na2HPO4 (25 mm, pH 8.0) containing 10% D2O], pre-
pared identically to the reaction mixture without AcCoA and Eis
(Table S9). Proton connectivity of 3’’,6’-diacetyl-Tob was assigned
by using zTOCSY and gCOSY spectra. Representative spectra for
3’’,6’-diacetyl-Tob and the Tob standard are provided in Figures
S46–S48 and S43–S45, respectively.
Disc diffusion assays of antibiotic activity of AGs before and
after acetylation by Eis : E. coli BL21 (DE3) and Mycobacterium
smegmatis MC2–155 cultures were grown on plates containing
20 mL of Luria-Bertani soft agar at 37 8C overnight. Acetylation re-
actions containing AG (Amk, Kan, Net, Sis, or Tob; 1 mm), AcCoA
(5 mm), and Eis (5 mm) in Tris (50 mm, pH 8.0) were carried out to
completion, as described above, with each AG. Twenty microliters
of each reaction was spotted on a sterile filter paper disc (0.5 cm
in diameter) and incubated at 37 8C overnight. On the same plates,
20 mL of of each AG (1 mm) in the same buffer was spotted on
paper discs. The antibiotic activity of all five AGs, as evidenced by
the prominent zones of inhibition for the parent drugs, was abol-
ished by the acetylation of the AGs by Eis (Figure 4).
Cloning, purification, and acetylation activity of EisC204A :
EisC204A was constructed by splicing-by-overlap-extension.[17] The
sequences downstream and upstream of the mutation were indi-
vidually amplified from pEis-pET28a(NHis) using primers #1:5’-
CTGCTGGCAGAAgcgAAAGCCGCGCCCG-3’ with #2:5’-CTAGCAG-
GATCCTCAGAACTCGAACGCG-3’ and #3:5’-CCGCGGCATATGCTA-
CAGTCGGATTC-3’ with #4:5’-CGGGCGCGGCTTTcgcTTCTGCCAGCAG-
3’, respectively. These PCR products served as templates for anoth-
er PCR with primers #2 and #3. This PCR product was subcloned
into NdeI/BamHI-linearized pET28a. EisC204A was purified similarly
to wild-type Eis,[5] concentrated, and stored at 4 8C. The activity of
EisC204A was tested against ten AGs by a UV/Vis assay[5] (Fig-
ure S49).
Crystal structure determination of EisC204A-CoA-TOB complex:
Crystals of the EisC204A-CoA-Tob complex were grown in hanging
drops (22 8C, 2 months) consisting of a mixture of EisC204A (1 mL,
3.5 mgmL1) in Tris·HCl (50 mm, pH 8.0, containing Tob (1 mm) and
CoA (1 mm) and reservoir solution (1 mL, Tris·HCl (100 mm, pH 8.5)
and PEG 8,000 (13%, w/v)), equilibrated against 1 mL of reservoir
solution. The crystals were gradually transferred into cryoprotec-
tant solution (Tris·HCl (100 mm, pH 8.5), PEG 8,000 (13%, w/v), glyc-
erol (20%), Tob (40 mm), and CoA (5 mm)), and rapidly frozen in
liquid nitrogen.
The X-ray diffraction data were collected at beam line 21ID of the
APS at the Argonne National Laboratory at 100 K and processed
with HKL2000[18] (Table 2). The structure was determined by molec-
ular replacement with Phaser[19] using the Eis hexamer from our
previous structure (PDB ID: 3R1K[5]) as a search model. The struc-
ture contained one Eis hexamer per asymmetric unit. After rigid-
body and NCS-restrained refinement with Refmac,[20] six CoAs (one
per monomer) were positioned in the difference electronic density,
as in our previous structure.[5] The FoFc map revealed a strong dif-
ference density for Tob in two of the six binding sites. Tob could
be modeled into this density and refined equally well in either of
the two possible conformations, due to the pseudo-symmetry of
Tob and data resolution limitations. The structure was refined with
three sets of NCS restraints, one for six Eis monomers, one for six
CoAs, and one for two Tobs.
Analysis of solvent-accessible surface area (ASA): The ASA calcu-
lations for the structure of EisC204A-CoA-Tob complex and struc-
tures of other complexes of AG-modifying enzymes with Tob avail-
able in the PDB were performed with Surface Racer[21] (Tables S10
and S11).
Data deposition : The PDB accession code for the structure of
EisC204A-CoA-Tob complex is 4JD6.
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